ATE536172T1 - Ezetimibzusammensetzungen - Google Patents

Ezetimibzusammensetzungen

Info

Publication number
ATE536172T1
ATE536172T1 AT10156084T AT10156084T ATE536172T1 AT E536172 T1 ATE536172 T1 AT E536172T1 AT 10156084 T AT10156084 T AT 10156084T AT 10156084 T AT10156084 T AT 10156084T AT E536172 T1 ATE536172 T1 AT E536172T1
Authority
AT
Austria
Prior art keywords
ezetimibe
methods
pharmaceutically acceptable
ezetimibe compositions
compositions
Prior art date
Application number
AT10156084T
Other languages
English (en)
Inventor
Uemit Cifter
Levent Oener
Ali Tuerkyilmaz
Ibrahim Murat Uezer
Gaye Ramazanoglu
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Application granted granted Critical
Publication of ATE536172T1 publication Critical patent/ATE536172T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
AT10156084T 2009-03-13 2010-03-10 Ezetimibzusammensetzungen ATE536172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR200901961 2009-03-13

Publications (1)

Publication Number Publication Date
ATE536172T1 true ATE536172T1 (de) 2011-12-15

Family

ID=41064574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT10156084T ATE536172T1 (de) 2009-03-13 2010-03-10 Ezetimibzusammensetzungen

Country Status (5)

Country Link
US (1) US9095515B2 (de)
EP (1) EP2229938B9 (de)
AT (1) ATE536172T1 (de)
ES (1) ES2382773T3 (de)
PL (1) PL2229938T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2468258A1 (de) * 2010-12-22 2012-06-27 LEK Pharmaceuticals d.d. Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung, die einen wenig löslichen, pharmazeutisch wirksamen Bestandteil umfasst
CN103655481A (zh) * 2012-09-18 2014-03-26 江苏柯菲平医药有限公司 一种依折麦布口服制剂制备方法
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CN104161752B (zh) * 2013-05-16 2018-09-07 江苏豪森药业集团有限公司 一种维格列汀组合物
KR20150079373A (ko) * 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
MX2017011499A (es) 2015-03-13 2018-03-26 Esperion Therapeutics Inc Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
US20180338922A1 (en) * 2017-05-26 2018-11-29 Esperion Therapeutics, Inc. Fixed dose formulations
EP3437636A1 (de) 2017-08-02 2019-02-06 Adamed sp. z o.o. Pharmazeutische zusammensetzung mit ezetimibe
CN109718215A (zh) * 2017-10-30 2019-05-07 海南皇隆制药股份有限公司 一种依折麦布片
EP3591700A1 (de) 2018-07-02 2020-01-08 Thomson Licensing Bildsensor mit einem farbteiler mit zwei verschiedenen brechungsindizes und unterschiedlicher höhe
CN115252565B (zh) * 2022-05-30 2023-09-19 国药集团致君（深圳）制药有限公司 一种依折麦布片及其制备工艺和溶出评价方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
TWI337083B (en) 2001-01-26 2011-02-11 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
CN101394837A (zh) * 2006-03-06 2009-03-25 特瓦制药工业有限公司 折替米贝组合物
US20070275052A1 (en) 2006-05-24 2007-11-29 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing sterol inhibitors
WO2008101723A2 (en) 2007-02-23 2008-08-28 Krka Pharmaceutical composition containing a cholesterol absorption inhibitor

Also Published As

Publication number Publication date
EP2229938A1 (de) 2010-09-22
EP2229938B1 (de) 2011-12-07
US20100234342A1 (en) 2010-09-16
PL2229938T3 (pl) 2012-09-28
US9095515B2 (en) 2015-08-04
ES2382773T3 (es) 2012-06-13
EP2229938B9 (de) 2012-04-25

Similar Documents

Publication Publication Date Title
ATE536172T1 (de) Ezetimibzusammensetzungen
CY1123810T1 (el) Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
MY187047A (en) Selective pyy compounds and uses thereof
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
EP4071149A3 (de) Heterocyclische verbindungen und verwendungen davon
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
MX2020011449A (es) Oxiesteroles y metodos de uso de los mismos.
CY1119007T1 (el) Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης
PH12018500061A1 (en) Oxysterols and methods of use thereof
PE20121617A1 (es) Derivados de oxazina como inhibidores de bace
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
ATE517882T1 (de) Chinolinderivate
EP4316591A3 (de) Oxysterole und verfahren zu ihrer verwendung
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
EA202090688A1 (ru) Бис-амидные соединения, активирующие саркомер, и варианты их применения
MX2014000341A (es) Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
MX2016006053A (es) Compuestos selectivos de peptido yy (pyy) y usos de los mismos.
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
NZ746825A (en) Oxysterols and methods of use thereof
EA201170689A1 (ru) Противомикробные композиции
PH12017500029A1 (en) 4,5-dihydroisoxazole derivatives as nampt inhibitors
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
WO2009140341A3 (en) Atorvastatin compositions